Proof of principle clinical study of nomacopan in patients with COVID-19 pneumonia
Latest Information Update: 18 Dec 2020
At a glance
- Drugs Nomacopan (Primary) ; Dexamethasone; Remdesivir
- Indications COVID 2019 infections; Pneumonia
- Focus Therapeutic Use
- Sponsors Akari Therapeutics
- 11 Dec 2020 Status changed from active, no longer recruiting to suspended to optimize dosing due to a subset of patients whose complement levels did not remain fully ablated, indicating an unexpectedly high complement drive as recently reported by others , according to an Akari Therapeutics media release.
- 07 Sep 2020 New trial record